Delivery Order SPE2DB24D2003-SPE2DB25FXLR1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $6,857.16, was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,930.67 delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $24,071.89 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units). This firm fixed-price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a $3,984.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). The contract, which is not set-aside and was competitively awarded, is scheduled for completion by August 11, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Kerendia 10 mg tablets (30-count units). This firm fixed-price delivery order, valued at $15,382.34, was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $5,954.02 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,153.92, is for the supply of 4,568,131,493 units of the medication Kerendia 20 mg tablets. The order is a firm fixed-price contract with a completion date of May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) with a ceiling value of $2,330.76. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the drug Kerendia 10 mg Tablet 30s, with a ceiling value of $3,377.11 and a completion date of October 23, 2024. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition. As a large IDC...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLR1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,842.64 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will be completed by August 14, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare systems. AmerisourceBergen Drug Corp's IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, medical supplies, and specialty medications across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. The contractor's extensive federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements and deliver diverse pharmaceutical commodities efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 8/13/25 |